Predictive oncology announces ceo raymond vennare to present at the bio international convention 2024

Presentation to highlight company's novel application of ai/machine learning capabilities utilizing its proprietary biobank of more than 150,000 tumor samples to guide leading biopharma partners through early oncologic drug discovery presentation to highlight company's novel application of ai/machine learning capabilities utilizing its proprietary biobank of more than 150,000 tumor samples to guide leading biopharma partners through early oncologic drug discovery
POAI Ratings Summary
POAI Quant Ranking